1.5 minute read
The White House released its plan to vaccinate children between the ages of 5-11, pending authorization from the U.S. Food and Drug Administration (FDA) for COVID-19.
The administration has obtained enough COVID-19 Pfizer doses for the 28 million children in that age range. Here are a few of the plan highlights:
- If authorized by the FDA and recommended by the Centers for Disease Control and Prevention (CDC), children ages 5-11 will receive a dose and formula specific to their age group. The Department of Health and Human Services (HHS) is working with states to ensure the vaccine is available across the country as rapidly as possible.
- The administration will partner with facilities providing the shots. The goal is to work with the same doctors and facilities families have depended on as trusted sources amid the pandemic.
- The HHS will conduct a national public education campaign to provide families with the information they need to make informed choices.
The upcoming meetings for the FDA and CDC will focus on COVID-19 vaccines for children. The White House says that children will be ready to begin getting shots days after the final CDC recommendation.
Download the bulletin for more details.
This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.
National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.
